Availability of data and material
The datasets during or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable
References
van Dooijeweert C, van Diest PJ, Ellis IO (2021) Grading of invasive breast carcinoma: the way forward. Virchows Arch. https://doi.org/10.1007/s00428-021-03141-2
WHO Classification of Tumours Editorial Board (2019) Breast tumours, 5th edn, 2 edn. International Agency for Research on Cancer. (WHO classification of tumours series), Lyon
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. https://doi.org/10.2307/2529310
van Dooijeweert C, van Diest PJ, Willems SM et al (2019) Significant inter-and intra-laboratory variation in grading of invasive breast cancer: a nationwide study of 33,043 patients in the Netherlands. Int J Cancer. https://doi.org/10.1002/ijc.32330
Knuttel FM, Menezes GLG, van Diest PJ et al (2016) Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen. Br J Surg 103(6):644–655. https://doi.org/10.1002/bjs.10128
Focke CM, Decker T, van Diest PJ (2016) The reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions. Histopathology. https://doi.org/10.1111/his.13036
Rakha EA, El-Sayed ME, Lee AH et al (2008) Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 26(19):3153–3158. https://doi.org/10.1200/JCO.2007.15.5986
Amat S, Penault-Llorca F, Cure H et al (2002) Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol. https://doi.org/10.3892/ijo.20.4.791
Abrial C, Mouret-Reynier MA, Amat S et al (2005) Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers. Med Oncol 22(3):233–240. https://doi.org/10.1385/mo:22:3:233
Waaijer L, Willems SM, Verkooijen HM et al (2015) Impact of preoperative evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer. Br J Surg 102(9):1048–1055. https://doi.org/10.1002/bjs.9858
Author information
Authors and Affiliations
Contributions
Rodrigo Justi Nogueira: data collection and paper writing; Thales Müller Silvério Alves: data collection and article writing; Mário Jefferson Quirino Louzada: statistical analyses; Deolino João Camilo Júnior: microscopic analysis; José Cândido Caldeira Xavier Júnior: study design, microscopic analysis, and paper review.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Research Ethics Committee of the Unisalesiano/Araçatuba, São Paulo, Brazil (CAAE 36593120.0.0000.5379).
Consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nogueira, R.J., Alves, T.M.S., Louzada, M.J.Q. et al. Agreement between core needle biopsy and surgical excision product: the importance of the invasive breast carcinoma grading system. Virchows Arch 480, 713–714 (2022). https://doi.org/10.1007/s00428-021-03246-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-021-03246-8